Emactuzumab in TGCT: Primary Results From the Phase 3 TANGENT Trial Medical Education on ReachMD

Name: Emactuzumab in TGCT: Primary Results From the Phase 3 TANGENT Trial
Uploaded: 2026-10-28T04:00:00+00:00
Duration: 4 min 54 s
Description: Teno-synovial giant cell tumor (TGCT) is a rare, locally aggressive disease that can cause substantial pain, stiffness, functional impairment, and joint de